These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30032383)

  • 1. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease-a UK Biobank sub-study, with an appendix of interesting cases.
    Mojtahed A; Kelly CJ; Herlihy AH; Kin S; Wilman HR; McKay A; Kelly M; Milanesi M; Neubauer S; Thomas EL; Bell JD; Banerjee R; Harisinghani M
    Abdom Radiol (NY); 2019 Jan; 44(1):72-84. PubMed ID: 30032383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of liver fat in the UK Biobank cohort.
    Wilman HR; Kelly M; Garratt S; Matthews PM; Milanesi M; Herlihy A; Gyngell M; Neubauer S; Bell JD; Banerjee R; Thomas EL
    PLoS One; 2017; 12(2):e0172921. PubMed ID: 28241076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis.
    Dennis A; Kelly MD; Fernandes C; Mouchti S; Fallowfield JA; Hirschfield G; Pavlides M; Harrison S; Chakravarthy MV; Banerjee R; Sanyal A
    Front Endocrinol (Lausanne); 2020; 11():575843. PubMed ID: 33584535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
    Roca-Fernandez A; Banerjee R; Thomaides-Brears H; Telford A; Sanyal A; Neubauer S; Nichols TE; Raman B; McCracken C; Petersen SE; Ntusi NA; Cuthbertson DJ; Lai M; Dennis A; Banerjee A
    J Hepatol; 2023 Nov; 79(5):1085-1095. PubMed ID: 37348789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis.
    Parisinos CA; Wilman HR; Thomas EL; Kelly M; Nicholls RC; McGonigle J; Neubauer S; Hingorani AD; Patel RS; Hemingway H; Bell JD; Banerjee R; Yaghootkar H
    J Hepatol; 2020 Aug; 73(2):241-251. PubMed ID: 32247823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.
    Hong CW; Mamidipalli A; Hooker JC; Hamilton G; Wolfson T; Chen DH; Fazeli Dehkordy S; Middleton MS; Reeder SB; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2018 Apr; 47(4):995-1002. PubMed ID: 28851124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity is inversely associated with hepatic fibro-inflammation: A population-based cohort study using UK Biobank data.
    Sherry AP; Willis SA; Yates T; Johnson W; Razieh C; Sargeant JA; Malaikah S; Stensel DJ; Aithal GP; King JA
    JHEP Rep; 2023 Jan; 5(1):100622. PubMed ID: 36440257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver.
    Bachtiar V; Kelly MD; Wilman HR; Jacobs J; Newbould R; Kelly CJ; Gyngell ML; Groves KE; McKay A; Herlihy AH; Fernandes CC; Halberstadt M; Maguire M; Jayaratne N; Linden S; Neubauer S; Banerjee R
    PLoS One; 2019; 14(4):e0214921. PubMed ID: 30970039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis B.
    Hui RW; Chiu KW; Mak LY; Chang HC; Cheung KS; Fung J; Yuen MF; Seto WK
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1139-1147. PubMed ID: 35368120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of liver T1 relaxation times without and with iron correction in pediatric autoimmune liver disease.
    Dillman JR; Serai SD; Miethke AG; Singh R; Tkach JA; Trout AT
    Pediatr Radiol; 2020 Jun; 50(7):935-942. PubMed ID: 32409910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.
    Hooker JC; Hamilton G; Park CC; Liao S; Wolfson T; Dehkordy SF; Hong CW; Mamidipalli A; Gamst A; Loomba R; Sirlin CB
    Abdom Radiol (NY); 2019 Feb; 44(2):482-492. PubMed ID: 30128694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of liver iron by magnetic resonance imaging in the UK Biobank population.
    McKay A; Wilman HR; Dennis A; Kelly M; Gyngell ML; Neubauer S; Bell JD; Banerjee R; Thomas EL
    PLoS One; 2018; 13(12):e0209340. PubMed ID: 30576354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Kühn JP; Meffert P; Heske C; Kromrey ML; Schmidt CO; Mensel B; Völzke H; Lerch MM; Hernando D; Mayerle J; Reeder SB
    Radiology; 2017 Sep; 284(3):706-716. PubMed ID: 28481195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
    Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
    Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
    Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
    J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of magnetic resonance imaging (MRI) iron corrected T1 in monitoring metabolic dysfunction-associated steatohepatitis in obesity following bariatric surgery and lifestyle modification: a prospective cohort study.
    Chiyanika C; Hui SCN; Sin DMC; Shumbayawonda E; Wong SKH; Ng EKW; Yip TC; Wong VW; Chu WCW
    Quant Imaging Med Surg; 2024 Jul; 14(7):4659-4674. PubMed ID: 39022255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study.
    Amanatidou AI; Kaliora AC; Amerikanou C; Stojanoski S; Milosevic N; Vezou C; Beribaka M; Banerjee R; Kalafati IP; Smyrnioudis I; Kurth MJ; Kannt A; Francino MP; Visvikis-Siest S; Deloukas P; Llorens C; Marascio F; Milic N; Medic-Stojanoska M; Gastaldelli A; Trivella MG; Dedoussis GV
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreases in cT1 and liver fat content reflect treatment-induced histological improvements in MASH.
    Alkhouri N; Beyer C; Shumbayawonda E; Andersson A; Yale K; Rolph T; Chung RT; Vuppalanchi R; Cusi K; Loomba R; Pansini M; Dennis A
    J Hepatol; 2024 Sep; ():. PubMed ID: 39326675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease.
    McCrary J; Trout AT; Mahalingam N; Singh R; Rojas CC; Miethke AG; Dillman JR
    AJR Am J Roentgenol; 2022 Jul; 219(1):142-150. PubMed ID: 35080454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.